Clinical Trials
- Diabetes
Hydroxychloroquine in Individuals At-risk for Type 1 Diabetes Mellitus (TN-22)
- Ages3 years and older
- GenderBoth
- Date11/26/2018
- Brain, Spinal Cord & Nervous System
Imaging pancreatic beta-cells with PET neuroimaging agent 11C-PHNO
- Ages18 years - 65 years
- GenderBoth
- Date09/05/2017
- Brain, Spinal Cord & Nervous System, Diabetes, Endocrine System
Impact of Hypoglycemia on Brain Ketone and Neurotransmitter Metabolism in Type 1 DM
- Ages18 years and older
- GenderBoth
- Date09/29/2012
- Children's Health, Diabetes, Endocrine System
Pathway to Prevention Study
- Ages1 year - 45 years
- GenderBoth
- Date09/16/2006
- Diabetes
Recent-Onset Type 1 Diabetes Trial Evaluating Efficacy and Safety of Teplizumab (PROTECT)
- Ages8 years - 17 years
- GenderBoth
- Date09/10/2019
- Diabetes
TrialNet TOPPLE Study for People with Type 1 Diabetes
- Ages18 years - 45 years
- GenderBoth
- Date11/17/2020
- Children's Health, Diabetes
Type 1 Diabetes Extension Study (T1DES)
- Ages8 years - 35 years
- GenderBoth
- Date05/06/2016